Sareum Holdings Plc (LON:SAR) saw its shares soar higher on Thursday as analysts at Hybridan spotlighted a read-across from the launch of big pharma takeover deal in the US.
The small-cap broker’s analysts noted that Bristol-Myers Squibb Co. …
Drug discovery group Sareum Holdings Plc (LON:SAR) will tell investors 2018 has been a year of significant progress.
At the company’s annual meeting, being held in the City of London, chairman Dr Stephen Parker will point to the progress of S…
RT @sierraoncology: Sierra sponsors the DNA Damage Response Therapeutics Summit next week in Boston. On Jan 30, CSO Dr. Chris Hassig will p…
via @Sareumplc